Characterization of systolic and diastolic function, alongside proteomic profiling, in doxorubicin-induced cardiovascular toxicity in mice
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Characterization of systolic and diastolic function, alongside proteomic profiling, in doxorubicin-induced cardiovascular toxicity in mice ; volume:10 ; number:1 ; day:22 ; month:6 ; year:2024 ; pages:1-17 ; date:12.2024
Cardio-Oncology ; 10, Heft 1 (22.6.2024), 1-17, 12.2024
- Creator
-
Krüger, Dustin N.
Bosman, Matthias
Assche, Charles X.L. Van
Wesley, Callan D.
Cillero-Pastor, Berta
Delrue, Leen
Heggermont, Ward
Bartunek, Jozef
Meyer, Guido R. Y. De
Craenenbroeck, Emeline M. Van
Guns, Pieter-Jan
Franssen, Constantijn
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s40959-024-00241-1
- URN
-
urn:nbn:de:101:1-2409161044308.313673178718
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:27 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Krüger, Dustin N.
- Bosman, Matthias
- Assche, Charles X.L. Van
- Wesley, Callan D.
- Cillero-Pastor, Berta
- Delrue, Leen
- Heggermont, Ward
- Bartunek, Jozef
- Meyer, Guido R. Y. De
- Craenenbroeck, Emeline M. Van
- Guns, Pieter-Jan
- Franssen, Constantijn
- SpringerLink (Online service)
Other Objects (12)
Doxorubicin-induced ovarian toxicity
Empagliflozin prevents doxorubicin-induced myocardial dysfunction
Rifampicin efficacy against doxorubicin-induced cardiotoxicity in mice
MST1 mediates doxorubicin-induced cardiomyopathy by SIRT3 downregulation
A lysosome-targeted dextran-doxorubicin nanodrug overcomes doxorubicin-induced chemoresistance of myeloid leukemia
Iscador Qu inhibits doxorubicin-induced senescence of MCF7 cells
Diazoxide protects against doxorubicin-induced cardiotoxicity in the rat
Glycine protects against doxorubicin-induced heart toxicity in mice
PI3K inhibition enhances doxorubicin-induced apoptosis in sarcoma cells
The progression of doxorubicin-induced intestinal mucositis in rats
Doxorubicin-induced cardiotoxicity in adult Indian patients on chemotherapy
Calsyntenin-1 Promotes Doxorubicin-induced Dilated Cardiomyopathy in Rats
Doxorubicin-induced ovarian toxicity
Empagliflozin prevents doxorubicin-induced myocardial dysfunction
Rifampicin efficacy against doxorubicin-induced cardiotoxicity in mice
MST1 mediates doxorubicin-induced cardiomyopathy by SIRT3 downregulation
A lysosome-targeted dextran-doxorubicin nanodrug overcomes doxorubicin-induced chemoresistance of myeloid leukemia
Iscador Qu inhibits doxorubicin-induced senescence of MCF7 cells
Diazoxide protects against doxorubicin-induced cardiotoxicity in the rat
Glycine protects against doxorubicin-induced heart toxicity in mice
PI3K inhibition enhances doxorubicin-induced apoptosis in sarcoma cells
The progression of doxorubicin-induced intestinal mucositis in rats
Doxorubicin-induced cardiotoxicity in adult Indian patients on chemotherapy
Calsyntenin-1 Promotes Doxorubicin-induced Dilated Cardiomyopathy in Rats
Doxorubicin-induced ovarian toxicity
Empagliflozin prevents doxorubicin-induced myocardial dysfunction
Rifampicin efficacy against doxorubicin-induced cardiotoxicity in mice
MST1 mediates doxorubicin-induced cardiomyopathy by SIRT3 downregulation
A lysosome-targeted dextran-doxorubicin nanodrug overcomes doxorubicin-induced chemoresistance of myeloid leukemia
Iscador Qu inhibits doxorubicin-induced senescence of MCF7 cells
Diazoxide protects against doxorubicin-induced cardiotoxicity in the rat
Glycine protects against doxorubicin-induced heart toxicity in mice
PI3K inhibition enhances doxorubicin-induced apoptosis in sarcoma cells
The progression of doxorubicin-induced intestinal mucositis in rats
Doxorubicin-induced cardiotoxicity in adult Indian patients on chemotherapy